摘要
目的观察卡孕栓联合催产素或单独使用对产后出血的预防效果。方法将300例足月妊娠产妇随机分为3组,A组于胎儿娩出后给予催产素肌注,B组给予卡孕栓舌下含服,C组给予卡孕栓舌下含服联合催产素肌注,记录三组产后2 h、24 h出血量及产后出血率。结果 C组产后出血率低于A、B组(P<0.05);三组不良反应发生率比较差异无统计学意义(P>0.05);C组产后2 h、24 h出血量均少于A、B组(P<0.05);C组第三产程时间短于A、B组(P<0.05)。结论卡孕栓联合催产素预防产后出血效果优于单独用药,联合用药可有效缩短第三产程,降低产后出血率,改善母婴预后。
Objective To observe the effect of carprost joint or separate With oxytocin in the prevention of postpartum hemorrhage. Methods 300 cases of full-term pregnancy women were randomly divided into three groups, group A was given oxytocin intramuscularly, group B was given carprost inserted into the rectum, group C was given carprost inserted into the rectum combined with oxytocin intramuscularly ,postpartum 2 h ,24 h bleeding of three groups were recorded. Results Postpartum hemorrhage of group C was lower than that of group A and group B （ P 〈 0. 05 ） ; the incidence of adverse reactions of three groups had no significant difference （ P 〉 0. 05 ） ; postpartum 2 h ,24 h bleed- ing volume of group C were less than that in group A and group B （ P 〈 0. 05 ） ; third stage of labor of group C was shorter than that in group A and group B （ P 〈 0. 05 ）. Condusion Carprost joint oxytocin to prevent postpartum hem- orrhage is better than monotherapy, combination therapy can effectively shorten the third stage of labor, reduce postpar- tum hemorrhage rate, improve maternal and child outcomes.
出处
《实用药物与临床》
CAS
2014年第1期106-108,共3页
Practical Pharmacy and Clinical Remedies
关键词
产后出血
卡孕栓
催产素
第三产程
预防
Postpartum hemorrhage
Carprost
Oxytocin
Third stage of labor
Prevention
